Results 1 - 10 of 22 : 1 2 3 Next
The company presents more data on its molecular diagnostic and buys a lab to run the tests in.
With the stock hitting 52-week highs, what did investors expect to happen?
Targeted Medicine: Health Care's Next Big Thing
Tailoring drugs to smaller groups looks like the wave of the future.
5 Health Care Companies Flying Below the Radar
They've all got a potentially winning story.
It's important to kick the tires first.
Illumina Polishes Its Biochips
Who's going to complain about double-digit growth?
Predicting More Good News From Invitrogen
Invitrogen gets a positive review from the FDA for one of its tests.
Drugmakers: Not So Recession-Proof?
Pharmaceuticals and biopharmaceuticals are in the red for 2008.
A bullish market signal and positive CAPS sentiment might make a winning combination.
A Bridgeway Over Troubled Waters?
This aggressive fund did well last year, but will its strength last?
Legal Information © 1995 - 2008 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK